Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$242K Hold
3,130
0.06% 116
2022
Q3
$235K Hold
3,130
0.05% 120
2022
Q2
$235K Hold
3,130
0.05% 115
2022
Q1
$263K Hold
3,130
0.04% 124
2021
Q4
$207K Hold
3,130
0.03% 137
2021
Q3
$198K Hold
3,130
0.03% 131
2021
Q2
$207K Hold
3,130
0.03% 135
2021
Q1
$208K Buy
+3,130
New +$195K 0.03% 128
2020
Q3
Sell
-3,120
Closed -$203K 138
2020
Q2
$203K Buy
+3,120
New +$192K 0.04% 121
2020
Q1
Sell
-3,098
Closed -$244K 128
2019
Q4
$244K Buy
3,098
+8
+0.3% +$587 0.07% 110
2019
Q3
$229K Buy
3,090
+10
+0.3% +$700 0.08% 97
2019
Q2
$209K Buy
+3,080
New +$202K 0.09% 99
2018
Q3
Sell
-9,048
Closed -$525K 115
2018
Q2
$525K Buy
+9,048
New +$495K 0.31% 74

Other funds holding SRE

Burleson & Co's SRE Position: Q4 2022 in Review

Burleson & Co held its Sempra (SRE) position steady in Q4 2022 at 3,130 shares worth $242K. The position accounts for 0.06% of the portfolio, ranked #116.

Burleson & Co first reported a position in SRE in Q2 2018 and has held it in 13 quarters since. The position peaked at $525K in Q2 2018. 1,005 funds tracked by Wall St. Rank hold SRE as of Q4 2022.

  • Burleson & Co held 3,130 shares of Sempra worth $242K as of Q4 2022.
  • Burleson & Co left its Sempra share count unchanged in Q4 2022.
  • Sempra made up 0.06% of Burleson & Co's portfolio in Q4 2022, its #116 holding.
  • Burleson & Co first reported a position in Sempra in Q2 2018 and has held it in 13 quarters since.
  • Burleson & Co's Sempra position peaked at $525K in Q2 2018.
  • 1,005 funds tracked by Wall St. Rank held Sempra as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.